GL1X · GenesisL1 explorer

MolNFT v1 · #143394 · protein

Structure of the native full-length HIV-1 capsid protein in complex with CPSF6 peptide

6AY9: “Structure of the native full-length HIV-1 capsid protein in complex with CPSF6 peptide”. X-ray diffraction, 2 ligands (IOD, CL), 1 pocket (best druggability 0.38). MolNFT v1 #143394 on GenesisL1: 3D structure, binding sites and…

PDB
6AY9
Type
protein
Length
230 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
HIV-1 capsid protein; Cleavage and polyadenylation specificity factor subunit 6
UniProt
B6DRA0, Q16630
Ligands
IOD, CL
Pockets
1 · best druggability 0.38

Structure

x-ray diffraction · 2 distinct chains · 57% helix, 2% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AHIV-1 capsid proteinprotein21860% helix, 2% strandB6DRA0
BCleavage and polyadenylation specificity factor subunit 6protein120% helix, 0% strandQ16630

Ligands and binding sites

  • IOD · Iodide ion · ion · 6 copies · chains A
  • CL · Chloride ion · ion · 4 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
1610.380.7916empty

Interfaces

1 interface between chains.

  • A–B · 537 Ų buried · 8 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 1 disulfide (disulfide).

Compared structures

  • 6AY9 · Structure of the native full-length HIV-1 capsid protein in complex with CPSF6 peptide · the same entry in another collection · chain A against A, TM-score 1.00
  • Q16630 · AlphaFold monomer V2.0 prediction for cleavage and polyadenylation specificity factor… · a predicted model of the same protein · chain B against A, TM-score 0.37

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.